220 related articles for article (PubMed ID: 15139452)
1. Treatment of latent TB infection for close contacts as a complementary TB control strategy in Singapore.
Chee CB; Teleman MD; Boudville IC; Do SE; Wang YT
Int J Tuberc Lung Dis; 2004 Feb; 8(2):226-31. PubMed ID: 15139452
[TBL] [Abstract][Full Text] [Related]
2. A prospective cohort study of latent tuberculosis in adult close contacts of active pulmonary tuberculosis patients in Korea.
Park SH; Lee SJ; Cho YJ; Jeong YY; Kim HC; Lee JD; Kim HJ; Menzies D
Korean J Intern Med; 2016 May; 31(3):517-24. PubMed ID: 27052266
[TBL] [Abstract][Full Text] [Related]
3. Contact screening and latent TB infection treatment in Singapore correctional facilities.
Chee CB; Teleman MD; Boudville IC; Wang YT
Int J Tuberc Lung Dis; 2005 Nov; 9(11):1248-52. PubMed ID: 16333933
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of LTBI treatment for TB contacts in British Columbia.
Tan MC; Marra CA; Sadatsafavi M; Marra F; Morán-Mendoza O; Moadebi S; Elwood RK; FitzGerald JM
Value Health; 2008; 11(5):842-52. PubMed ID: 18489519
[TBL] [Abstract][Full Text] [Related]
5. Tuberculosis incidence among contacts of active pulmonary tuberculosis.
Cailleaux-Cezar M; de A Melo D; Xavier GM; de Salles CL; de Mello FC; Ruffino-Netto A; Golub JE; Efron A; Chaisson RE; Conde MB
Int J Tuberc Lung Dis; 2009 Feb; 13(2):190-5. PubMed ID: 19146746
[TBL] [Abstract][Full Text] [Related]
6. A quantitative benefit-risk analysis of isoniazid for treatment of latent tuberculosis infection using incremental benefit framework.
Sadatsafavi M; Marra C; Marra F; Moran O; FitzGerald JM; Lynd L
Value Health; 2013; 16(1):66-75. PubMed ID: 23337217
[TBL] [Abstract][Full Text] [Related]
7. Contact evaluation and isoniazid preventive therapy among close and household contacts of tuberculosis patients in Lima, Peru: an analysis of routine data.
Otero L; Battaglioli T; Ríos J; De la Torre Z; Trocones N; Ordoñez C; Seas C; Van der Stuyft P
Trop Med Int Health; 2020 Mar; 25(3):346-356. PubMed ID: 31758837
[TBL] [Abstract][Full Text] [Related]
8. Tuberculin skin testing compared with T-cell responses to Mycobacterium tuberculosis-specific and nonspecific antigens for detection of latent infection in persons with recent tuberculosis contact.
Arend SM; Engelhard AC; Groot G; de Boer K; Andersen P; Ottenhoff TH; van Dissel JT
Clin Diagn Lab Immunol; 2001 Nov; 8(6):1089-96. PubMed ID: 11687445
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of interferon-gamma release assay screening for latent tuberculosis infection treatment in Germany.
Diel R; Nienhaus A; Loddenkemper R
Chest; 2007 May; 131(5):1424-34. PubMed ID: 17494792
[TBL] [Abstract][Full Text] [Related]
10. Risk for Tuberculosis Disease Among Contacts with Prior Positive Tuberculin Skin Test: A retrospective Cohort Study, New York City.
Gounder PP; Harris TG; Anger H; Trieu L; Meissner JS; Cadwell BL; Shashkina E; Ahuja SD
J Gen Intern Med; 2015 Jun; 30(6):742-8. PubMed ID: 25605533
[TBL] [Abstract][Full Text] [Related]
11. The presence of a booster phenomenon among contacts of active pulmonary tuberculosis cases: a retrospective cohort.
Salles CG; Ruffino-Netto A; Lapa-e-Silva JR; Kritski AL; Cailleaux-Cesar M; Queiroz-Mello FC; Conde MB
BMC Public Health; 2007 Mar; 7():38. PubMed ID: 17371600
[TBL] [Abstract][Full Text] [Related]
12. Role of QuantiFERON(®)-TB Gold In-Tube in tuberculosis contact investigation: experience in a tuberculosis unit.
Gonzślez-Moreno J; García-Gasalla M; Gállego-Lezaun C; Fernández-Baca V; Mir Viladrich I; Cifuentes-Luna C; Serrano Bujalance A; Salom Vallespir A; Payeras Cifre A
Infect Dis (Lond); 2015 Apr; 47(4):244-51. PubMed ID: 25692351
[TBL] [Abstract][Full Text] [Related]
13. Bacillus Calmette-Guérin and isoniazid preventive therapy protect contacts of patients with tuberculosis.
Zelner JL; Murray MB; Becerra MC; Galea J; Lecca L; Calderon R; Yataco R; Contreras C; Zhang Z; Grenfell BT; Cohen T
Am J Respir Crit Care Med; 2014 Apr; 189(7):853-9. PubMed ID: 24592878
[TBL] [Abstract][Full Text] [Related]
14. Is the T-cell-based interferon-gamma releasing assay feasible for diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country?
Dilektasli AG; Erdem E; Durukan E; Eyüboğlu FÖ
Jpn J Infect Dis; 2010 Nov; 63(6):433-6. PubMed ID: 21099095
[TBL] [Abstract][Full Text] [Related]
15. Tuberculosis infection in children who are contacts of immigrant tuberculosis patients.
Verver S; van Loenhout-Rooyackers JH; Bwire R; Annee-van Bavel JA; de Lange HJ; van Gerven PJ; Borgdorff MW
Eur Respir J; 2005 Jul; 26(1):126-32. PubMed ID: 15994399
[TBL] [Abstract][Full Text] [Related]
16. Nosocomial exposure to active pulmonary tuberculosis in a neonatal intensive care unit.
Ahn JG; Kim DS; Kim KH
Am J Infect Control; 2015 Dec; 43(12):1292-5. PubMed ID: 26307044
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of Quantiferon-TB Gold and tuberculin skin test in patients with tuberculosis, close contact of patients, health care workers and tuberculosis laboratory personnel].
Cesur S; Hoca NT; Tarhan G; Cimen F; Ceyhan I; Annakkaya AN; Aslan T; Birengel S
Mikrobiyol Bul; 2010 Oct; 44(4):553-60. PubMed ID: 21063967
[TBL] [Abstract][Full Text] [Related]
18. Refined tuberculosis contact tracing in a low incidence area.
Ansari S; Thomas S; Campbell IA; Furness L; Evans MR
Respir Med; 1998 Sep; 92(9):1127-31. PubMed ID: 9926167
[TBL] [Abstract][Full Text] [Related]
19. Modelling the cost-effectiveness of strategies to prevent tuberculosis in child contacts in a high-burden setting.
Mandalakas AM; Hesseling AC; Gie RP; Schaaf HS; Marais BJ; Sinanovic E
Thorax; 2013 Mar; 68(3):247-55. PubMed ID: 22717944
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of contact investigations of infectious tuberculosis patients.
Marks SM; Taylor Z; Qualls NL; Shrestha-Kuwahara RJ; Wilce MA; Nguyen CH
Am J Respir Crit Care Med; 2000 Dec; 162(6):2033-8. PubMed ID: 11112109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
